Clinical Significance of Serum Angiopoietin-1 in Malignant Peritoneal Mesothelioma
Authors:
- 6 September 2013
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 31 (8) , 511-515
Abstract
We have previously reported that angiopoietin-1 was correlated with pulmonary fibrosis. Here, we investigated the serum levels of angiopoietin-1 in patients with malignant peritoneal mesothelioma, which originate from mesenchymal cells similar to lung fibroblasts. We showed that patients with peritoneal mesothelioma had significantly higher serum levels of angiopoietin-1 in comparison with a population with a history of asbestos exposure without peritoneal mesothelioma, and the Kaplan–Meier method revealed a significant correlation between serum angiopoietin-1 levels and survival. This is the first report about the relationship between angiopoietin-1 and peritoneal mesothelioma.Keywords
This publication has 20 references indexed in Scilit:
- Diffuse malignant peritoneal mesothelioma: Systematic review of clinical management and biological researchJournal of Surgical Oncology, 2011
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional ExperienceJournal of Clinical Oncology, 2009
- Malignant peritoneal mesothelioma: a multicenter study on 81 casesAnnals of Oncology, 2009
- Occupational, domestic and environmental mesothelioma risks in the British population: a case–control studyBritish Journal of Cancer, 2009
- Consensus statement on peritoneal mesotheliomaJournal of Surgical Oncology, 2008
- Epidemiology of peritoneal mesothelioma: a reviewAnnals of Oncology, 2006
- Advances in Malignant MesotheliomaNew England Journal of Medicine, 2005
- Asbestos Exposure, Pleural Mesothelioma, and Serum Osteopontin LevelsNew England Journal of Medicine, 2005
- Malignant mesotheliomaThe Lancet, 2005
- Mesothelin-family proteins and diagnosis of mesotheliomaThe Lancet, 2003